Woo Cheal Cho, MD

Woo Cheal Cho, MD Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from Woo Cheal Cho, MD, Doctor, Houston, TX.

Dermatopathologist, Assistant Professor, University of Texas MD Anderson Cancer Center | Fellow of the College of American Pathologists (FCAP) | USCAP Ambassador |

Looking for a unique fellowship experience? 😆🔬 has spots open! You’ll see once-in-a-lifetime cases (quite often) and ...
10/22/2025

Looking for a unique fellowship experience? 😆🔬

has spots open! You’ll see once-in-a-lifetime cases (quite often) and learn from some of the best in the field.

If you’re even a little interested, apply! You won’t regret it.

10/22/2025

A 52-year-old man with a history of splenectomy and hypogammaglobulinemia after CAR T-cell therapy for lymphoma 3 years earlier was admitted with septic shock. Encapsulated diplococci were seen in 20% of neutrophils.

It’s been a hectic time with nonstop clinical work and pending projects/manuscripts, so I almost forgot about my feature...
10/11/2025

It’s been a hectic time with nonstop clinical work and pending projects/manuscripts, so I almost forgot about my feature in this magazine. I’ve shared my personal perspective on the essential components we all need as pathologists. Take a look! 😆🔬

deadline is approaching!Remember those last-minute abstracts with 4-digit numbers often end up as platform presentatio...
10/04/2025

deadline is approaching!

Remember those last-minute abstracts with 4-digit numbers often end up as platform presentations? 😂🔬

Meanwhile, authors waiting for their manuscript reviews to wrap up be like... 😅

This skin punch biopsy shows spongiotic and superficial perivascular dermatitis with occasional parakeratotic mounds and...
09/12/2025

This skin punch biopsy shows spongiotic and superficial perivascular dermatitis with occasional parakeratotic mounds and extravasated red blood cells.

In the appropriate clinical context, these histopathologic features are consistent with pityriasis rosea (PR). However, keep in mind that PR-like drug eruptions can also show similar findings. 😆🔬

08/30/2025

A 71-year-old man presented with a 2-year history of a gradually darkening line on his left thumbnail. What is the most likely diagnosis? https://nej.md/IC08282025

It’s been a while since I shared a case.Did you know this immunoprofile, especially the diffuse TRPS1 immunoreactivity, ...
08/06/2025

It’s been a while since I shared a case.

Did you know this immunoprofile, especially the diffuse TRPS1 immunoreactivity, strongly favors primary EMPD over secondary EMPD? Give it a try if you haven’t used it in your practice. 😆🔬

07/21/2025

Oscar goes to Dr. Glaucomflecken. No movie script beats lines like:

“It’s a frozen. It’s not anesthesia trying to wake a patient up.”

“You’re wound up tighter than a keratin pearl.”

I see my surgical colleagues at frozen all the time — hoping one day I’ll catch my gas colleagues there too (after surgery, of course)! 😂🔬

🔥 Hot off the press: I’m tired of people equating the presence of a fusion with a Spitz tumor. It’s NOT that simple—tumo...
07/13/2025

🔥 Hot off the press: I’m tired of people equating the presence of a fusion with a Spitz tumor. It’s NOT that simple—tumors don’t always follow the textbook! Many bona fide melanomas of non-Spitz lineage can harbor fusions.

For example, some BRAF-fused melanomas of non-Spitz lineage may be characterized by prominent organoid and nested growth patterns, rhabdoid cytomorphology, and occasional Reed–Sternberg–like cells (arrow).

The article is free access—check it out if you love & ! 😆🔬

06/20/2025

🔥 Hot off the press! A striking increase in gamma/delta T-cells in subcutaneous panniculitis-like T-cell lymphoma (SPTCL) can be a major diagnostic pitfall—one that might lead to confusion with primary cutaneous gamma delta T-cell lymphoma. Recognizing this pitfall is crucial to avoid misclassification. A must-read for fellow and enthusiasts! 😆🔬



🔥 Hot off the press! TROP2 is one of the hottest biomarkers in oncology, especially with TROP2-directed antibody drug co...
06/18/2025

🔥 Hot off the press! TROP2 is one of the hottest biomarkers in oncology, especially with TROP2-directed antibody drug conjugates now available. Did you know that cutaneous squamous cell carcinomas and certain adnexal carcinomas—such as porocarcinoma, hidradenocarcinoma, pilomatrical carcinoma, and squamoid eccrine ductal carcinoma—show high TROP2 expression? Check it out if you love and . The article is free for 50 days. 😆🔬

Address

Houston, TX

Website

Alerts

Be the first to know and let us send you an email when Woo Cheal Cho, MD posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Featured

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category